Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2024

New developments in genetic modification of immune cells

Optimising cell engineering for cancer therapy

Date

11 Dec 2024

Session

New developments in genetic modification of immune cells

Topics

Tumour Immunology;  Translational Research;  Molecular Oncology;  Cell-Based Therapy;  Immunotherapy

Tumour Site

Presenters

Melita Irving

Authors

M. Irving

Author affiliations

  • UNIL - Ludwig Institute for Cancer Research - Lausanne Branch, Epalinges/CH

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.